Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360-degree synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of chronic diseases
3.2.1.2 Rising demand for personalised and targeted therapies
3.2.1.3 Growing R&D investment accelerated activities
3.2.1.4 Advancement in drug delivery technology
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of development and manufacturing
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Pipeline analysis
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Drug Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Antibiotics
5.3 Chemotherapy agents
5.4 Skeletal muscle relaxants
5.5 Anaesthetics
5.6 Anticoagulants
5.7 Anticonvulsants
5.8 Antivirals
5.9 Other drug types
Chapter 6 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Branded
6.3 Generics
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Intravenous (IV)
7.3 Intramuscular (IM)
7.4 Subcutaneous (SC)
Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Oncology
8.3 Infectious diseases
8.4 Diabetes
8.5 Musculoskeletal
8.6 Autoimmune disorders
8.7 Cardiovascular diseases
8.8 CNS disorders
8.9 Other applications
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospital pharmacies
9.3 Retail pharmacies
9.4 Online pharmacies
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 AbbVie Inc.
11.2 Amgen Inc.
11.3 AstraZeneca Plc.
11.4 BioCryst Pharmaceuticals, Inc.
11.5 Bristol-Myers Squibb Company
11.6 Eisai Co., Ltd.
11.7 Eli Lilly and Company
11.8 Fresenius Kabi USA
11.9 Gilead Sciences, Inc.
11.10 Merck KGaA
11.11 Novartis AG
11.12 Pfizer Inc.
11.13 Sanofi
11.14 Sun Pharmaceutical Industries Ltd.
11.15 Teva Pharmaceutical Industries Ltd.
